KELSEY WARD: Open Payments
NPI 1720448616 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 15 payments from 9 companies in 2025. Trend: 2023 $428 · 2024 $205 · 2025 $846
Food & beverage: $777Education: $69
| Company | Payments | Amount |
|---|---|---|
| La Jolla Pharmaceutical Company | 2 | $261 |
| SANOFI-AVENTIS U.S. LLC | 4 | $219 |
| Incyte Corporation | 1 | $130 |
| Medline Industries LP | 1 | $72 |
| Stemline Therapeutics Inc. | 2 | $62 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Legend Biotech USA Inc. | 1 | $21 |
| SERVIER PHARMACEUTICALS LLC | 1 | $18 |
Products named: XACDURO, REZUROCK, Niktimvo, ELZONRIS, PREVYMIS, Vanflyta, CARVYKTI, Tibsovo.
Industry payments across FL — which companies pay providers there.
